Skip to content
Disclosery

EXANE DERIVATIVES: HD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on HD, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3 HD shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3 shares
    Change vs previous 13F -410 shares

    <0.01% of the 13F portfolio, value $823.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 413 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $123,624.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 413 shares
    Change vs previous 13F -1,240 shares

    0.04% of the 13F portfolio, value $171,405.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,653 shares
    Change vs previous 13F +216 shares

    0.14% of the 13F portfolio, value $542,635.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,437 shares
    Change vs previous 13F +1,212 shares

    0.11% of the 13F portfolio, value $455,611.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 225 shares
    Change vs previous 13F -334 shares

    0.02% of the 13F portfolio, value $68,684.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 559 shares
    Change vs previous 13F +98 shares

    0.05% of the 13F portfolio, value $148,488.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 461 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $128,028.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).